Canada House Wellness Group Continues Strategic Transformation with the Announcement of Changes to its Board of Directors
TORONTO, Aug. 10, 2018 – Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce the appointment to its Board of Directors of Dennis Moir, Norman Betts and Chris Churchill-Smith.
Mr. Moir is an accomplished financial and operational executive with significant experience in strategy formulation and mergers and acquisitions. Throughout his career, spanning over 3 decades, Mr. Moir has held various senior financial and operational management positions with some of Canada’s more progressive technology and digital communication companies including Chief Financial Officer of PC DOCS Group International, BlueCat Networks and most recently Chief Financial Officer and Chief Operating Officer of CNW Group (a.k.a. Canada Newswire).
Mr. Moir has over 18 years of solid board experience both as an executive and non-executive director. His most recent board positions include Chair of Habitat for Humanity Greater Toronto Area and currently sits as a director and Chair of the Finance, Audit, Risk Management committee for this organization. He also currently sits as director for De’Longi Canada Inc.
Mr. Moir holds a Bachelor of Commerce degree from the University of Toronto, and is a CPA, CA. He is also a member of the Institute of Corporate Directors and holds an ICD.D.
Dr. Norman Betts is a Professor, Faculty of Business Administration at the University of New Brunswick (UNB), a Chartered Professional Accountant Fellow (FCA, FCPA) and a member of the Institute of Corporate Directors (ICD.D). A recognized leader in corporate governance and strategy, Dr. Betts has served on the boards of the Bank of Canada, Export Development Canada, New Brunswick Power, and Tembec Inc., as well as a number of emerging companies including Biotricity Inc. and Adex Mining Inc. He is also a co-chair of the board of trustees of the UNB Pension Plan for Academic Employees. He was Minister of Finance and Minister of Business New Brunswick with the Province of New Brunswick (1999-2003). He was awarded a PhD in Management from the School of Business at Queen’s University in 1992.
Chris Churchill-Smith is the Company’s Chief Executive Officer. Please refer to the Company’s press release dated June 1, 2018 for Mr. Churchill-Smith’s biography.
Concurrent with the appointment of Mr. Moir, Mr. Betts, and Mr. Churchill-Smith to the Board of Directors, the Board received and accepted the resignations of Matthew Appleby, Larry Bortles, Nicole Ferris, Paul Methot, Riley McGee, and Stephanus Jansen van Vuuren.
After giving effect to the appointments and resignations described above, the Board will be comprised of Scott Purdy (Chair), Norman Betts, Chris Churchill-Smith, Dennis Moir and Mike Southwell.
“On behalf of the Board of Directors, I would like to thank the resigning directors, particularly outgoing independent director Matt Appleby, each of whom have made extraordinary contributions to shape the vision and growth of Canada House Wellness Group. As Canada House continues on its strategic path in pursuit of its goal of being a leading medical cannabinoid therapy company, following industry best practices in regard to board composition means having a meaningful independent representation. Canada House achieved that goal tonight and we are very excited. To that end I would also like to welcome Dennis, Norm, and Chris to the board. Your expertise and experience will provide significant enhancement to our goal of providing support and resources to Canada House’s Senior leadership team.” commented Scott Purdy.
In connection with the resignations of the Directors, an aggregate of 2,950,000 stock options originally granted on December 22, 2017 at an exercise price of $0.47 were cancelled. Also in connection with the resignations of the Directors, an aggregate of 950,000 warrants to purchase common shares were issued having an exercise price of $0.20 and expiring on August 9, 2022.
Canada House Wellness Group Inc.
Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp. The Company’s goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated cannabis therapy company. For more information please visit http://www.canadahouse.ca or www.sedar.com
For further information, please contact:
Boom Capital Markets
Canada House Wellness Group Inc.
Cautionary Statement Regarding Forward Looking Information.
Certain statements within this news release pertaining to the Company may constitute “forward looking statements”, within the meaning of applicable securities laws. Forward-looking statements may be identified by the use of terminology such as “believes,” “expects,” “anticipates,” “assumes,” “plans,” or other similar words. Such forward-looking statements involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.